• innovative diabetes treatment
• Foreign entity Digen Pharmaceuticals will benefit from FDA approval of the product.

Duration: May 2, 2011 to May 2, 2012

General Issues: Foreign Relations, Health Issues, Pharmacy

Spending: about $220,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2011: House of Representatives, U.S. Senate, U.S. Senate,, Health & Human Services - Dept of (HHS), Natl Security Council (NSC), State - Dept of (DOS), Treasury - Dept of

Related Foreign Entities: Digen Pharmaceuticals GmbH (1010 Vienna, AUT); contribution to lobbying: $0; ownership 100%